Satellos Bioscience Stock Performance
| MSCL Stock | 0.83 0.04 5.06% |
On a scale of 0 to 100, Satellos Bioscience holds a performance score of 3. The entity has a beta of -0.36, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Satellos Bioscience are expected to decrease at a much lower rate. During the bear market, Satellos Bioscience is likely to outperform the market. Please check Satellos Bioscience's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to make a quick decision on whether Satellos Bioscience's existing price patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Satellos Bioscience are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Satellos Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:20 | Last Split Date 2021-08-18 |
1 | Satellos Bioscience to Present at November Investor Conferences - TipRanks | 10/30/2025 |
2 | Will Satellos Bioscience Inc. stock beat revenue estimates - Weekly Market Outlook Stock Portfolio Risk Control - newser.com | 11/06/2025 |
3 | Can Satellos Bioscience Inc. stock sustain institutional flows - Earnings Overview Report Consistent Return Strategy Ideas - newser.com | 11/14/2025 |
4 | Can Satellos Bioscience Inc. stock sustain institutional flows - 2025 Stock Rankings AI Enhanced Execution Alerts - newser.com | 11/17/2025 |
5 | Is Satellos Bioscience Inc. stock a fit for income portfolios - Weekly Gains Report Weekly Watchlist for Hot Stocks - newser.com | 11/20/2025 |
6 | Technical Analysis and Trading Signals - news.stocktradersdaily.com | 11/26/2025 |
7 | Satellos cleared to start SAT-3247 Phase 2 DMD trial in 51 children - Stock Titan | 12/09/2025 |
8 | Will Satellos Bioscience Inc. stock outperform benchmarks - Market Growth Review Real-Time Volume Analysis Alerts - | 12/18/2025 |
9 | Stock Evaluation Report - Stock Traders Daily | 12/30/2025 |
10 | Satellos Bioscience Set For Growth As Momentum Builds Fast - Kalkine Media | 01/08/2026 |
| Begin Period Cash Flow | 22.1 M | |
| Total Cashflows From Investing Activities | 6.3 M |
Satellos |
Satellos Bioscience Relative Risk vs. Return Landscape
If you would invest 78.00 in Satellos Bioscience on October 11, 2025 and sell it today you would earn a total of 5.00 from holding Satellos Bioscience or generate 6.41% return on investment over 90 days. Satellos Bioscience is generating 0.2055% of daily returns and assumes 4.5955% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Satellos, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Satellos Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Satellos Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Satellos Bioscience, and traders can use it to determine the average amount a Satellos Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0447
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MSCL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.6 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Satellos Bioscience is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Satellos Bioscience by adding it to a well-diversified portfolio.
Satellos Bioscience Fundamentals Growth
Satellos Stock prices reflect investors' perceptions of the future prospects and financial health of Satellos Bioscience, and Satellos Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Satellos Stock performance.
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | 106 M | ||||
| Shares Outstanding | 185.51 M | ||||
| Price To Book | 3.27 X | ||||
| Gross Profit | (16.68 M) | ||||
| EBITDA | (28.08 M) | ||||
| Net Income | (28.1 M) | ||||
| Cash And Equivalents | 40.07 M | ||||
| Total Debt | 5.16 M | ||||
| Book Value Per Share | 0.26 X | ||||
| Cash Flow From Operations | (24.98 M) | ||||
| Earnings Per Share | 0.30 X | ||||
| Market Capitalization | 153.97 M | ||||
| Total Asset | 73.02 M | ||||
| Retained Earnings | (75.6 M) | ||||
About Satellos Bioscience Performance
By examining Satellos Bioscience's fundamental ratios, stakeholders can obtain critical insights into Satellos Bioscience's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Satellos Bioscience is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (5.70) | (5.99) | |
| Return On Capital Employed | (2.25) | (2.36) | |
| Return On Assets | (2.10) | (2.21) | |
| Return On Equity | (3.87) | (3.67) |
Things to note about Satellos Bioscience performance evaluation
Checking the ongoing alerts about Satellos Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Satellos Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Satellos Bioscience has some characteristics of a very speculative penny stock | |
| Satellos Bioscience had very high historical volatility over the last 90 days | |
| Net Loss for the year was (28.1 M) with loss before overhead, payroll, taxes, and interest of (16.68 M). | |
| Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Satellos Bioscience Set For Growth As Momentum Builds Fast - Kalkine Media |
- Analyzing Satellos Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Satellos Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Satellos Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Satellos Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Satellos Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Satellos Bioscience's stock. These opinions can provide insight into Satellos Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.